Use of Sedation by a Hospital Palliative Care Support Team

Abstract

Get full access to this article

View all access options for this article.

References

Fainsinger

, Bruera

When to treat dehydration in a terminally ill patient?

Support Care Cancer 1997; 5: 205–211.

Fonderas

Sedation and ethical contradiction. Euro J Palliat Care 1996; 3: 17–20.

Craig

. On withholding nutrition and hydration in the terminally ill: has palliative medicine gone too tar? J Med Ethics 1994; 20: 139–143.

Cherny

, Portenoy

. Sedation in the management of refractory symptoms: guidelines for evaluation and treatment. J Palliat Care 1994; 10(1): 31–38.

Billings

, Block

. Slow euthanasia. J Palliat Care 1996; 12(4): 21–30.

Mount

. Morphine drips, terminal sedation, and slow euthanasia: definitions and facts, not anecdotes. J Palliat Care 1996; 12(4): 31–37.

Portenoy

. Morphine infusions at the end of life: the pitfalls in reasoning from anecdote. J Palliat Care 1996; 12(4): 44–46.

Stone

, Phillips

, Spruit

, Waight

A comparison of the use of sedatives in a hospital support team and in hospice. Palliat Med 1997; 11: 140–144.

Ventafridda

, Ripamonti

, deConno

, Symptom prevalence and control during cancer patients last days of life. J Palliat Care 1990; 6(3): 7–11.

10.

Burke

, Diamond

, Hulbert

, Yeatman

, Farr

. Terminal restlessness — its management and the role of midazolam. Med J Austr 1991; 155: 485–487.

11.

Morita

, Inoue

, Chihara

Sedation for symptom control in Japan: the importance of intermittent use and communication with family members. J Pain Sympt Manag 1996; 12: 32–38.

12.

Fainsinger

, Tapper

, Bruera

A perspective on the management of delirium in terminally ill patients on a palliative care unit. J Palliat Care 1993; 9(3): 4–8.

13.

Gram

. Fluoxetine. N Engl J Med 1994; 20: 1354–1361.

14.

Preskorn

, Beber

, Faul

, Hirschfeld

. Serious adverse effects of combining fluoxetine and tricyclic antidepressants. Am J Psychiatr 1990; 147: 532.

15.

Nemeroff

, DeVane

, Pollock

. Newer antidepressants and the cytochrome P450 system. Am J Psychiatr 1996; 153: 311–320.

16.

Compendium of Pharmaceuticals and Specialties, 32nd Edition. Ottawa: Canadian Pharmaceutical Association, 1997; pp. 1266–1267.

17.

de Stoutz

, Tapper

, Fainsinger

. Reversible delirium in terminally ill patients. J Pain Sympt Manag 1995; 10: 249–253.

18.

Fainsinger

, Bruera

Case report: is this opioid analgesic tolerance?

J Pain Sympt Manag 1995; 10(7): 573–577.

19.

Fainsinger

, Miller

, Bruera

Morphine intoxication during acute reversible renal insufficiency (Letter to the Editor). J Palliat Care 1992; 8(2): 52–53.

20.

Fainsinger

, Schoeller

, Boiskin

, Bruera

Palliative care round: cognitive failure and coma after renal failure in a patient receiving captopril and hydromorphone. J Palliat Care 1993; 9(1): 53–55.

21.

Bruera

, Franco

, Maltoni

, Watanabe

, Suraez-Almazor

Changing pattern of agitated impaired mental status in patients with advanced cancer: association of cognitive monitoring, hydration, and opioid rotation. J Pain Sympt Manag 1995; 10: 287–291.

22.

Pereira

, Hanson

, Bruera

The frequency and clinical cause of cognitive impairment in patients with terminal cancer. Cancer 1997; 79: 835–842.